JP2023521161A5 - - Google Patents

Info

Publication number
JP2023521161A5
JP2023521161A5 JP2022561995A JP2022561995A JP2023521161A5 JP 2023521161 A5 JP2023521161 A5 JP 2023521161A5 JP 2022561995 A JP2022561995 A JP 2022561995A JP 2022561995 A JP2022561995 A JP 2022561995A JP 2023521161 A5 JP2023521161 A5 JP 2023521161A5
Authority
JP
Japan
Prior art keywords
compound
use according
respiratory
infection
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521161A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/087501 external-priority patent/WO2021209003A1/en
Publication of JP2023521161A publication Critical patent/JP2023521161A/ja
Publication of JP2023521161A5 publication Critical patent/JP2023521161A5/ja
Pending legal-status Critical Current

Links

JP2022561995A 2020-04-15 2021-04-15 臓器傷害の予防及び処置 Pending JP2023521161A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/084820 2020-04-15
CN2020084820 2020-04-15
CNPCT/CN2021/081574 2021-03-18
CN2021081574 2021-03-18
PCT/CN2021/087501 WO2021209003A1 (en) 2020-04-15 2021-04-15 Prevention and treatment of organ injuries

Publications (2)

Publication Number Publication Date
JP2023521161A JP2023521161A (ja) 2023-05-23
JP2023521161A5 true JP2023521161A5 (cg-RX-API-DMAC7.html) 2024-04-24

Family

ID=78085285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561995A Pending JP2023521161A (ja) 2020-04-15 2021-04-15 臓器傷害の予防及び処置

Country Status (9)

Country Link
US (1) US12465629B2 (cg-RX-API-DMAC7.html)
EP (1) EP4135743A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023521161A (cg-RX-API-DMAC7.html)
KR (1) KR20230002589A (cg-RX-API-DMAC7.html)
CN (2) CN114245744A (cg-RX-API-DMAC7.html)
AU (1) AU2021256222A1 (cg-RX-API-DMAC7.html)
CA (1) CA3174545A1 (cg-RX-API-DMAC7.html)
TW (1) TWI889805B (cg-RX-API-DMAC7.html)
WO (1) WO2021209003A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
JPH08298986A (ja) * 1995-04-28 1996-11-19 Asahi Chem Ind Co Ltd ホスホリパーゼa2酵素
KR970064620A (ko) 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
ATE254630T1 (de) 1998-06-12 2003-12-15 Chem Ag C Cyclosporine
CN101068829B (zh) 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
WO2007041632A2 (en) * 2005-09-30 2007-04-12 Scynexis, Inc. Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
BRPI0708424A2 (pt) 2006-03-02 2011-05-31 Alexion Pharma Inc prolongamento da sobreviência de uma aloenxerto por inibição da atividade do complemento
CA2652662C (en) * 2006-05-19 2015-11-03 Scynexis, Inc. Methods for the treatment and prevention of ocular disorders
WO2008143996A1 (en) 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
US8536114B2 (en) 2008-12-31 2013-09-17 Scynexis, Inc. Macrocycles
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
MX350746B (es) * 2010-12-03 2017-09-14 Hebei Kunxiangjishi Pharmaceutical Tech Co Ltd Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Mebmt側鏈已環化之環孢菌素衍生物
CN105983095B (zh) * 2015-02-15 2019-09-13 艾棣维欣(苏州)生物制药有限公司 一种呼吸道合胞体病毒疫苗及其制备方法与应用
CN106902346A (zh) 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 药物组合物及其制药用途
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 亲环孢素抑制剂的用途
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
CN111449050A (zh) 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) * 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
WO2021190603A1 (en) 2020-03-26 2021-09-30 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
AU662509B2 (en) Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
JP6067047B2 (ja) 薬物動態の改善のためのエアゾールフルオロキノロン配合物
JP2015517489A5 (cg-RX-API-DMAC7.html)
JP2019528320A5 (cg-RX-API-DMAC7.html)
JP2016513688A5 (cg-RX-API-DMAC7.html)
CA3131137C (en) Methods of treatment of respiratory disorders
CN102724983A (zh) 雾化左氧氟沙星治疗囊性纤维化的用途
JP2023521030A5 (cg-RX-API-DMAC7.html)
UA119774C2 (uk) Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
JP2022534776A5 (cg-RX-API-DMAC7.html)
JP2023520917A (ja) 呼吸器状態を処置するためのtrpc6阻害剤
US12514830B2 (en) Idebenone for the treatment of Acute Respiratory Distress Syndrome (ARDS) in patients diagnosed with a coronavirus infection
JP2013518061A5 (cg-RX-API-DMAC7.html)
CN113694177B (zh) 器官损伤的预防和治疗
JP2017516767A (ja) サルコイドーシスを処置するための1,3−プロパンジスルホン酸またはその薬学的に許容される塩の使用
JP2021532165A5 (cg-RX-API-DMAC7.html)
JP6021952B2 (ja) 慢性閉塞性肺疾患の治療法
WO2025020917A1 (zh) 用于治疗脏器纤维化相关疾病的药物组合物和方法
JP2018510153A5 (cg-RX-API-DMAC7.html)
CN118055765A (zh) 用于治疗脓毒症的trpc6抑制性化合物
NZ758839B2 (en) Glycopeptide derivative compounds and uses thereof
Flume 4 Pulmonary Exacerbations in Bronchiectasis